Sign in

CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company

ADC Therapeutics SA

Sign in to watch
Ticker
ADCT
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
Phone
41 21 653 02 00
Business address
BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
  1. 4 Other disposition See Explanations disposed of 451,856 shares (other)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 26,758 shares (to pay taxes)
  3. 4 Grant or award Chief Legal Officer acquired 220,000 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 230,000 shares (grant or award)
  5. 4 Grant or award Chief Accounting Officer acquired 41,900 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 240,000 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 650,000 shares (grant or award)
  8. 4 Open-market buy 10% owner bought 200,000 shares at an average $3.05 ($609,000)
  9. 4 Shares withheld for taxes Chief Medical Officer gave up 37,112 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Accounting Officer gave up 6,503 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 48,108 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Legal Officer gave up 41,458 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 238,343 shares (to pay taxes)
  14. 4 Open-market sale 10% owner sold 25,352 shares at $2.07 ($52,479)
  15. 4 Open-market buy 10% owner bought 800,000 shares at $2.81 ($2,248,000)
  16. 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
  17. 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
  18. 4 Open-market sale Director sold 1,193 shares at $2.89 ($3,448)
  19. 4 Open-market sale Director sold 1,437 shares at $2.89 ($4,153)
  20. 4 Open-market sale Director sold 1,437 shares at $2.89 ($4,153)

Page 3 of 5 · 88 filings